<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/427864</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;427864</article-id><article-id pub-id-type="other" hwp:sub-type="slug">427864</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">427864</article-id><article-id pub-id-type="other" hwp:sub-type="tag">427864</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Neuroscience" hwp:journal="biorxiv"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Subcutaneous Neurotrophin-3 infusion induces corticospinal neuroplasticity and improvements in dexterity and walking in elderly rats after large cortical stroke</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>#</label>Corresponding author: Dr Lawrence Moon, Neurorestoration Group, Wolfson Centre for Age-Related Diseases, 16 – 18 Newcomen Street, London, SE1 1UL, United Kingdom, Tel: +44 7929 364035, Email: <email hwp:id="email-1">lawrence.moon@kcl.ac.uk</email></corresp><fn id="n1" fn-type="conflict" hwp:id="fn-1"><p hwp:id="p-1">The authors have declared that no conflict of interest exists.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Duricki Denise"><surname>Duricki</surname><given-names>Denise</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2284-8347</contrib-id><name name-style="western" hwp:sortable="Kakanos Sotiris"><surname>Kakanos</surname><given-names>Sotiris</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-2284-8347"/></contrib><contrib contrib-type="author" hwp:id="contrib-3"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5144-534X</contrib-id><name name-style="western" hwp:sortable="Haenzi Barbara"><surname>Haenzi</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-5144-534X"/></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Wayman Christina"><surname>Wayman</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8777-3003</contrib-id><name name-style="western" hwp:sortable="Bödecker Nora"><surname>Bödecker</surname><given-names>Nora</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8777-3003"/></contrib><contrib contrib-type="author" hwp:id="contrib-6"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2984-0831</contrib-id><name name-style="western" hwp:sortable="Vogelgesang Antje"><surname>Vogelgesang</surname><given-names>Antje</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-2984-0831"/></contrib><contrib contrib-type="author" hwp:id="contrib-7"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5021-1234</contrib-id><name name-style="western" hwp:sortable="Cash Diana"><surname>Cash</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-5021-1234"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-8"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9622-0312</contrib-id><name name-style="western" hwp:sortable="Moon Lawrence"><surname>Moon</surname><given-names>Lawrence</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">#</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-9622-0312"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5"><label>1</label><institution hwp:id="institution-1">Neurorestoration Group, Wolfson Centre for Age-Related Diseases, King’s College London</institution>, 16–18 Newcomen Street, London SE1 1UL, <country>UK</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-2">Centre for Integrative Biology, King’s College London, Franklin-Wilkins Building</institution>, 150 Stamford Street, London SE1 9NH, <country>UK</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2"><label>3</label><institution hwp:id="institution-3">Department of Neurology, University Medicine, Greifswald</institution>, <country>Germany</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1"><label>4</label><institution hwp:id="institution-4">Neuroimaging Research Group, King’s College London</institution>, PO42 De Crespigny Park, London, SE5 8AF</aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-09-26T08:27:14-07:00">
    <day>26</day><month>9</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-08-06T22:33:10-07:00">
    <day>6</day><month>8</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-09-26T08:35:26-07:00">
    <day>26</day><month>9</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-08-06T22:37:37-07:00">
    <day>6</day><month>8</month><year>2021</year>
  </pub-date><elocation-id>427864</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-09-26"><day>26</day><month>9</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2021-08-05"><day>05</day><month>8</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-08-06"><day>06</day><month>8</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-2">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="427864.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/change-list" xlink:role="change-list" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/427864v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="427864.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/427864v2/427864v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/427864v2/427864v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-3">There is an urgent need for a therapy which reverses disability after stroke when initiated in a time frame suitable for the majority of new victims. Neurotrophin-3 (NT3) is a growth factor made by muscle spindles and skin which is required for the survival, development and function of locomotor circuits involving afferents from muscle and skin that mediate proprioception and tactile sensation. Its level declines in muscle and other tissues postnatally. We show that levels of NT-3 in the bloodstream were low in humans with ischemia stroke relative to young healthy controls. Accordingly, we set out to determine whether subcutaneous delivery of NT3 improves sensorimotor recovery after stroke in elderly rats. We show that one-month-long subcutaneous infusion of NT3 protein induces sensorimotor recovery after cortical stroke in elderly rats. Specifically, in a randomised, blinded pre-clinical trial, we show improved dexterity, walking and sensory function in rats following cortical ischemic stroke when treatment with NT3 is initiated 24 hours after stroke. Importantly, NT-3 was given in a clinically feasible time frame via this straightforward route. MRI and histology showed that recovery was not due to neuroprotection, as expected given the delayed treatment. Rather, anterograde tracing showed that corticospinal axons from the less-affected hemisphere sprouted in the spinal cord from cervical levels 2 to 8. Importantly, Phase I and II clinical trials by others show that repeated, subcutaneously administered high doses of recombinant NT-3 are safe and well tolerated in humans with other conditions. This paves the way for NT-3 as a therapy for stroke.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-2">Key words</title><kwd hwp:id="kwd-1">Neurotrophin 3</kwd><kwd hwp:id="kwd-2">stroke</kwd><kwd hwp:id="kwd-3">plasticity</kwd><kwd hwp:id="kwd-4">corticospinal</kwd><kwd hwp:id="kwd-5">sprouting</kwd></kwd-group><counts><page-count count="18"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-4">The authors have declared no competing interest.</p></notes><fn-group content-type="summary-of-updates" hwp:id="fn-group-1"><title hwp:id="title-4">Summary of Updates:</title><fn fn-type="update" hwp:id="fn-2"><p hwp:id="p-5">New data added: ELISA for NT3 in human blood. Now Figure 1 and Table 1. Methods revised. Text updated.</p></fn></fn-group></notes></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-5">Introduction</title><p hwp:id="p-6">Stroke rapidly kills brain cells and is frequently disabling. Globally, there are 31 million stroke survivors, with another 9 million new strokes annually (WHO). The majority of stroke victims are not admitted to hospital and diagnosed within six hours <sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref></sup> yet clot-busting therapies only work when treatment is initiated well within 4.5 hours. New therapies are urgently needed <sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>,<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup>.</p><p hwp:id="p-7">We are the first to study whether recombinant human neurotrophin-3 (NT-3) can improve recovery when given in a clinically-feasible time-frame after stroke. Others have shown that NT-3 plays a role in the development, function and repair of locomotor circuits <sup><xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>–<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref></sup> including reports that intracranial delivery of NT-3 immediately following stroke or by intracranial gene therapy prior to stroke reduces infarct volume <sup><xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>–<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref></sup>. Moreover, NT-3 restores sensorimotor function following spinal cord injury in rats <sup><xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>,<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>–<xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref></sup> by promoting axon growth and synaptic plasticity in multiple locomotor pathways including the corticospinal tract and proprioceptive pathways. All these systems express trkC and/or p75 receptors for NT-3 <sup><xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>–<xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref></sup>. We therefore examined the ability of NT-3 to promote recovery in a model of stroke.</p><p hwp:id="p-8">We chose to deliver NT-3 by the subcutaneous route for translational relevance. First, high, repeated subcutaneous doses of recombinant NT-3 are safe and well-tolerated in Phase I and II clinical trials for other disorders <sup><xref rid="c18" ref-type="bibr" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>–<xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup>. This is a clinically-straightforward route after ischemic stroke in humans. Peripherally administered neurotrophins accumulate in sensory ganglia where they can cause gene transcription, axon growth of primary afferents, and synapse strengthening within locomotor circuits <sup><xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref>,<xref rid="c22" ref-type="bibr" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>–<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref></sup>. Because &gt;90% of strokes occur in people older than 65 with comorbidities including carotid arterial stenosis<sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref></sup>, we evaluated the effectiveness of NT-3 in elderly rats with large cortical strokes caused by distal middle cerebral artery occlusion and common carotid occlusion<sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref></sup>. We chose to deliver our therapy 24 hours after cortical ischemia, because most stroke victims are admitted and diagnosed by this time<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>,<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref></sup>.</p><p hwp:id="p-9">We show that delayed NT-3 improves sensory and motor recovery after large cortical stroke in elderly rats.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-6">Results</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-7">Neurotrophin-3 levels in blood serum are low after stroke in elderly humans</title><p hwp:id="p-10">It has been shown previously that Neurotrophin-3 levels decline generally in most tissues in the postnatal period <sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>,<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref></sup>. We now show that whereas the level of Neurotrophin-3 in serum was modest in young healthy adults, the level was low in people after ischemic stroke (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1</xref>). Given these low levels, in the present study we sought to elevate the levels of Neurotrophin-3 after large cortical stroke in elderly rats.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1:</label><caption hwp:id="caption-1"><p hwp:id="p-11">ELISA of serum shows that NT-3 levels were very low in humans on admission to hospital after ischemic stroke relative to young healthy controls (Kruskal-Wallis p=0.0543; Dunn’s p=0.033). The level of NT-3 was not increased up to seven days after ischemic stroke (versus stroke at admission; Dunn’s p-values &gt;0.05). Numbers of subjects per group are shown on the graph. Other information can be found in <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>. Graph shows means and SEMs.</p></caption><graphic xlink:href="427864v2_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-12">Ischemic stroke was induced in the sensorimotor cortex representing each rat’s dominant forearm by permanent distal occlusion of the middle cerebral artery with tandem occlusion of the common carotid arteries <sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-3" hwp:rel-id="ref-29">29</xref></sup> (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2</xref>). Twenty-four hours later, rats were randomised to treatment with treatment allocations concealed using coded vials. Magnetic resonance imaging (MRI) was performed and then osmotic minipumps were implanted subcutaneously. Recovery of sensory and locomotor performance was assessed weekly for 12 weeks. Anterograde tracer was injected into the less-affected sensorimotor cortex 4 weeks before the end of each study. All surgeries and treatments were performed using a randomised block design and the experimenter was fully blinded to treatment allocation until all analyses were completed. The rats were euthanized at the end for histology.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1:</label><caption hwp:id="caption-2"><p hwp:id="p-13">Patients and Controls. NIHSS: National Institute of Health Stroke Scale; * data available for 45 patients.</p></caption><graphic xlink:href="427864v2_tbl1" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2:</label><caption hwp:id="caption-3"><p hwp:id="p-14">Delayed subcutaneous infusion of NT-3 did not reduce infarct volume in elderly rats. (A) Rats were randomised to treatment with recombinant NT-3 or vehicle from subcutaneous minipumps, implanted 24 hours after stroke (red). Behavioural testing was conducted for twelve weeks. The spared corticospinal tract was traced anterogradely (blue) eight weeks after onset of treatment. (B) MR images taken 24 hours after stroke show large cortical infarcts with no differences between groups (p&lt;0.05).</p></caption><graphic xlink:href="427864v2_fig2" position="float" orientation="portrait" hwp:id="graphic-3"/></fig></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-8">Delayed subcutaneous NT-3 did not neuroprotect</title><p hwp:id="p-15">MRI at 24 hours after stroke (immediately before treatment) showed that large infarcts involved motor cortex and somatosensory cortex as well as cortex rostral and caudal to these regions (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2</xref>). There were no differences between stroke groups in lesion volumes. Therefore, as expected from our previous work, stroke causes a focal infarct in sensorimotor cortex and loss of cortical efferents to the cervical spinal cord, and delayed treatment with NT3 does not cause neuroprotection (consistent with the delayed time frame of administration).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-9">Delayed subcutaneous NT-3 promoted sensory and motor recovery</title><p hwp:id="p-16">We assessed recovery of dexterity using the staircase test. Prior to stroke, elderly rats retrieved more than 80% of pellets with their dominant paw and more than 60% of pellets with their other paw (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3A</xref>). Stroke was induced in the hemisphere representing the dominant paw. One week after stroke, the two groups were impaired in reaching for pellets with their affected paw. Recovery was greater in the group of rats treated with NT-3 than those treated with vehicle (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3A</xref>).</p><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8 xref-fig-3-9 xref-fig-3-10 xref-fig-3-11"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3:</label><caption hwp:id="caption-4"><p hwp:id="p-17">Delayed subcutaneous infusion of NT-3 improved dexterity. (A) The “staircase test” was used to assess dexterity. After stroke, the two groups of rats were similarly impaired in their ability to reach for pellets with their affected forelimb (t-test, p=0.18). Recovery was greatest in the group of rats treated with NT-3 compared to vehicle (treatment × time F<sub>11,17</sub>=2.91, p=0.024). (B) The “horizontal ladder” test was used to assess accuracy of foot placement. One week after stroke, the two groups of stroke rats made a similar, large number of errors with their affected forelimb (t-test, p=0.96). Recovery was nearly complete in rats treated with NT-3 compared to vehicle (treatment × time F<sub>11,215</sub>=2.33, p=0.01). (C) The “sticky patch test” was used to assess the time taken first to contact and then to (D) remove stimuli on their forelimbs. After stroke, the two groups of rats were similarly slow to contact a sticky patch stuck to their affected wrist (t-test, p=0.91). Recovery was greatest in the group of rats treated with NT-3 compared to vehicle (treatment F<sub>1,21</sub>=7.2, p=0.014; treatment × time F<sub>11,20</sub>=2.6, p=0.31).</p></caption><graphic xlink:href="427864v2_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-18">We also assessed sensory responsiveness and dexterity using the sticky patch test. Stickers of equal radius were attached to each wrist and the time taken to contact and then remove them was measured (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3B</xref>). Prior to stroke, rats contacted the first sticker rapidly and then removed it rapidly. One week after stroke, both groups took longer to contact the first sticker (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Figure 3B</xref>). The stroke group treated with NT-3 recovered more fully than the stroke group treated with vehicle. Similarly, one week after stroke, both groups took longer to remove the first sticker (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Figure 3C</xref>). The stroke group treated with NT-3 recovered more fully than the stroke group treated with vehicle, removing it more rapidly.</p><p hwp:id="p-19">Finally, we assessed accuracy of limb placement during walking using a horizontal ladder with irregularly spaced rungs (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Figure 3D</xref>). Accuracy of limb placement requires proprioceptive sensory feedback from the limbs especially when rung spacing was changed frequently to avoid fixed stride lengths or other pattern learning <sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup>. Video recordings were assessed in slow motion to count the number of errors made with the affected forelimb (expressed as a percentage of steps). Prior to stroke, rats crossed the ladder making very few errors (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Figure 3D</xref>). One week after stroke, both groups of rats made a large, comparable number of errors with their affected forelimb. The stroke group treated with NT-3 recovered more fully then the stroke group treated with vehicle (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Figure 3D</xref>). In summary, delayed, subcutaneous treatment with NT-3 improved sensory and motor recovery after large cortical stroke.</p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-10">NT-3 induced neuroplasticity in the corticospinal tract</title><p hwp:id="p-20">Anterograde tracer (biotinylated dextran amine, BDA) was injected into the less-affected sensorimotor cortex 4 weeks prior to the end of the study (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2</xref>). Immunolabelling for BDA was used to assess axonal sprouting of this corticospinal tract. This decussates in the medullary pyramids and largely projects to the contralateral side of the spinal cord in the dorsal columns and in the dorsolateral columns; there is also a minor projection which does not decussate but runs in the ventral spinal cord (see inset in <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4</xref>). We chose to measure corticospinal tract axons in every cervical segment from C2 to C8 because the shoulder, forelimb and paw muscles are supplied by dorsal root ganglia (DRG) and motor neurons between C2 and C8 <sup><xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>,<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref></sup>. Corticospinal axons from the less-affected hemisphere were measured at three parasagittal planes on the denervated side (“Midline”, “Distance 1” and “Distance 2”; <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-9" hwp:rel-id="F3">Figure 3</xref>) and obliquely where ventral corticospinal axons that have projected ipsilaterally from cortex enter the grey matter (“Ipsi”; <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-10" hwp:rel-id="F3">Figure 3</xref>). <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-11" hwp:rel-id="F3">Figure 3</xref> shows representative pictures of corticospinal axons at C7. Neurotrophin-3 treatment increased corticospinal tract sprouting at all levels from C2 to C8 (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Figure 4</xref>). Sprouting was frequently observed at the midline, at distance 1, distance 2 and from the ventral corticospinal tract. Increased sprouting at distance 2 indicates that more corticospinal tract axons extended into the territory of the forelimb motor neuron pools which are located in lateral and ventrolateral grey matter (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Figure 4</xref>) <sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-3" hwp:rel-id="ref-28">28</xref>,<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-4" hwp:rel-id="ref-29">29</xref></sup>.</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4:</label><caption hwp:id="caption-5"><p hwp:id="p-21">NT-3 treatment caused plasticity of corticospinal axons in the cervical spinal cord. A-H) Anterogradely traced corticospinal axons were counted in the cervical cord segments C2 to C8 at the midline (M), at two more lateral planes (D1 and D2) and crossing into grey matter from the ipsilateral, ventral tract (Ipsi). I) Corticospinal tract axons (green) sprouted into the dorsal horn on the affected side amongst PKC gamma labelled sensory neurons (red). J) NT3 enhanced the number of corticospinal tract axons which sprouted into the laminae containing PKC gamma labelled sensory neurons.</p></caption><graphic xlink:href="427864v2_fig4" position="float" orientation="portrait" hwp:id="graphic-5"/></fig></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-11">NT-3 was transiently elevated in the bloodstream</title><p hwp:id="p-22">ELISA showed that NT-3 was elevated in the serum of elderly rats treated subcutaneously with NT3 relative to those treated with vehicle (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Figure 5</xref>) at 2 weeks after onset of treatment but not at 12 weeks (<italic toggle="yes">i.e.</italic>, 8 weeks after removal of minipumps). This was expected and is consistent with NT-3’s short half-life in serum<sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref></sup>.</p><fig id="fig5" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;427864v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Figure 5:</label><caption hwp:id="caption-6"><title hwp:id="title-12">Subcutaneous infusion of NT-3 enhanced levels of NT-3 in serum of elderly rats.</title><p hwp:id="p-23">ELISA showed that serum levels of NT-3 were elevated at 2 weeks (unpaired t-test, p&lt;0.001) but not 12 weeks (unpaired t-test, p&gt;0.05).</p></caption><graphic xlink:href="427864v2_fig5" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec></sec><sec id="s3" hwp:id="sec-8"><title hwp:id="title-13">Discussion</title><p hwp:id="p-24">We report that the level of Neurotrophin-3 in serum was modest in young healthy adult humans, whereas the level was low in elderly people and it remained low in elderly people after stroke whether measured at hospital admission or up to seven days later. A smaller study reported a very slight elevation in serum levels of NT-3 in patients with cortical infarcts <sup><xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-2" hwp:rel-id="ref-33">33</xref></sup>. Together these studies provide a motivation for exploring whether supplementation of NT-3 improves recovery after stroke.</p><p hwp:id="p-25">Subcutaneous treatment with NT-3, initiated 24 hours after stroke, caused changes in multiple spinal locomotor circuits, and promoted a progressive recovery of sensory and motor function in elderly rats. The fact that NT-3 can reverse disability even when initiated 24 hours after stroke is exciting because the vast majority of stroke victims are diagnosed within this time frame <sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">1</xref></sup> (which is not the case for the gold-standard drug for stroke, tPA, which needs to be given within a few hours and is only available to a minority). Thus, NT-3 could potentially be used to treat an enormous number of victims.</p><p hwp:id="p-26">NT-3 has good clinical potential. Firstly, it would be feasible to give hospitalised stroke patients subcutaneous infusions of recombinant NT-3. Secondly, Phase II clinical trials show that subcutaneous doses of NT-3 up to 150 μg/kg/day are well tolerated and safe in healthy humans and in humans with other conditions<sup><xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">18</xref>,<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">21</xref>,<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>,<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref></sup>, which paves the way for NT-3 as a therapy for stroke. We used a similar dose in this study: in future experiments, one might optimize the dose and duration of treatment because it is possible that a different dose of NT-3 would promote additional recovery after stroke, especially if combined with appropriate rehabilitation<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref></sup>. Secondly, there is good conservation from rodents to primates including humans in the expression of receptors for NT-3 in the locomotor system <sup><xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">15</xref>,<xref rid="c38" ref-type="bibr" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>–<xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref></sup>. Thirdly, in none of our rodent experiments has NT-3 treatment caused any detectable pain, spasticity or muscle weakness (in line with the human trials).</p><p hwp:id="p-27">Our work is relevant to recent work shedding light on the mechanisms whereby sensory cues enhance recovery after CNS injury in humans and other animals<sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">31</xref>,<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref></sup>. It has been proven that proprioceptive signals cause sprouting of descending locomotor pathways and enhance recovery after unilateral spinal cord injury because genetic depletion of muscle spindles attenuates central plasticity and impairs recovery<sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-3" hwp:rel-id="ref-31">31</xref></sup>. We now extend these findings by proving that NT-3 can cause sprouting of descending locomotor pathways and enhance locomotor recovery after unilateral stroke, even when onset of treatment is delayed by 24 hours. Thus, at least to some extent, subcutaneously infused NT-3 may mimic proprioceptive signalling after neurological injury. This idea is also consistent with work from postnatal mice showing that a single injection of NT-3 can restore monosynaptic connectivity between proprioceptive afferents and spinal motor neurons with genetically depleted muscle spindles <sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup>. We have now begun a program of work designed to dissect the mechanisms whereby NT-3 promotes recovery. We are currently testing the hypothesis that NT3 enters the DRG and causes changes in gene expression in proprioceptive neurons in adult rats after stroke, as has been shown in development, which then drives central changes <sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref></sup>. We and others have already shown that neurotrophins accumulate in sensory or sympathetic ganglia after subcutaneous, intravenous, intramuscular or intraneural administration following transport in the bloodstream or retrograde transport in nerves <sup><xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">27</xref>,<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>–<xref rid="c46" ref-type="bibr" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref></sup>. Many groups have shown that the dorsal root ganglia is highly vascularised and contain fenestrated endothelial cells which make its blood-nerve interface leaky to proteins as big as (or bigger than) neurotrophin-3. We now plan to use RNAseq to identify transcriptional changes in the DRG that might cause the functional recovery that we observe.</p><p hwp:id="p-28">In summary, treatment of elderly rats with NT-3 (initiated in a clinically-feasible time-frame) induces multilevel corticospinal neuroplasticity, improves sensory function, walking and dexterity.</p></sec><sec id="s4" hwp:id="sec-9"><title hwp:id="title-14">Methods</title><p hwp:id="p-29">Full Materials and Methods are available in Supplementary Information.</p><sec id="s4a" hwp:id="sec-10"><title hwp:id="title-15">Patients and Controls</title><p hwp:id="p-30">Stroke Patients were recruited at the Stroke Unit of the University Medicine Greifswald, Germany. Venous blood was sampled upon admission to the emergency room within 12h of stroke onset and on the morning of the days 1, 3, 5 and 7 thereafter. Patients with age &gt;18 years suffering from acute ischemic stroke were eligible for this study within 12 h of disease onset if their National Institute of Health Stroke Scale Score (NIHSS) was ≥ 6 and no signs of infection were detected (C-reactive protein ≤ 50 mg/L and procalcitonin ≤ 0.5 ng/mL). Patients were treated with standard medical care in a dedicated stroke unit and did not receive immune-suppressive drugs. Lysis by recombinant tissue plasminogen activator and thrombectomy were carried out as clinically indicated. Age-matched control individuals were either healthy or were recruited from the ophthalmology clinics from patients scheduled to receive cataract surgery. Young controls were healthy individuals. See Patient and control characteristics in <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>.</p></sec><sec id="s4b" hwp:id="sec-11"><title hwp:id="title-16">Ethics approval and consent to participate</title><p hwp:id="p-31">The study protocol was approved by the ethics committee of the Medical Faculty, University of Greifswald (No. III UV 30/01). All donors provided written informed consent directly or through a surrogate.</p></sec><sec id="s4c" hwp:id="sec-12"><title hwp:id="title-17">ELISA</title><p hwp:id="p-32">To gain serum, 5ml of venous blood were taken into BD vacutainer serum sampling tubes (SST II advanced, Ref 367955, Beckton Dickenson, Heidelberg, Germany). Tubes were centrifuged at 3000g for 5 min at room temperature. Aliquots were stored at −80°C. NT-3 was measured by standard ELISA according to manufacturer’s instructions (ab100615 – Neurotrophin 3 human ELISA Kit, abcam, Cambridge, United Kingdom).</p></sec><sec id="s4d" hwp:id="sec-13"><title hwp:id="title-18">Statistical analysis</title><p hwp:id="p-33">Human serum data sets were tested for adherence to the Gaussian distribution with the Kolmogorov-Smirnov test. Since the data failed the normality test, we used non-parametric testing throughout. The Kruskal-Wallis test with Dunn’s multiple comparison test as a post- test were used as appropriate. GraphPad-PRISM 5.0 (GraphPad Software inc., San Diego, CA, USA) was used for all analyses. A p-value &lt; 0.05 was regarded as significant.</p><sec id="s4d1" hwp:id="sec-14"><title hwp:id="title-19">Animal experiments</title><p hwp:id="p-34">53 elderly rats (aged ~20 months; Charles River, UK) were trained on behavioural tasks for 4 weeks prior to baseline scoring. Stroke was induced unilaterally in the sensorimotor cortex by permanent distal middle cerebral artery occlusion (MCAO) and tandem carotid occlusion, as described elsewhere <sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-5" hwp:rel-id="ref-29">29</xref></sup>. Twenty-four hours later, recombinant NT-3 or vehicle was infused subcutaneously for four weeks. Anaesthesia and analgesia were used. Rats were assessed for 12 weeks using the staircase test, horizontal ladder, and sticky patch tests. All surgeries, treatments and behavioural testing were performed blind using a randomized block design. Group codes were only broken after all analyses were completed. n=9-12/group were used for tract tracing. Behavioural data were analysed using linear models using baseline scores as covariates. Anterograde tracing data were assessed using one way ANOVA and <italic toggle="yes">post hoc</italic> t-tests. Threshold for significance was 0.05. Two-tailed tests were used. Data are presented as means ± SEM. Asterisks indicate *p ≤ 0.05; **p ≤ 0.01; *** p ≤ 0.001.</p></sec></sec></sec></body><back><ref-list hwp:id="ref-list-1"><title hwp:id="title-20">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3"><label>1</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Evenson K. R."><surname>Evenson</surname>, <given-names>K. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Foraker R. E."><surname>Foraker</surname>, <given-names>R. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morris D. L."><surname>Morris</surname>, <given-names>D. L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rosamond W. D."><surname>Rosamond</surname>, <given-names>W. D.</given-names></string-name> <article-title hwp:id="article-title-2">A comprehensive review of prehospital and in-hospital delay times in acute stroke care</article-title>. <source hwp:id="source-1">Int J Stroke</source> <volume>4</volume>, <fpage>187</fpage>–<lpage>199</lpage> (<year>2009</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Donnan G. A."><surname>Donnan</surname>, <given-names>G. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fisher M."><surname>Fisher</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Macleod M."><surname>Macleod</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Davis S. M."><surname>Davis</surname>, <given-names>S. M.</given-names></string-name> <article-title hwp:id="article-title-3">Stroke</article-title>. <source hwp:id="source-2">Lancet</source> <volume>371</volume>, <fpage>1612</fpage>–<lpage>1623</lpage> (<year>2008</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Carmichael S. T."><surname>Carmichael</surname>, <given-names>S. T.</given-names></string-name> <article-title hwp:id="article-title-4">Rodent models of focal stroke: size, mechanism, and purpose</article-title>. <source hwp:id="source-3">NeuroRx</source> <volume>2</volume>, <fpage>396</fpage>–<lpage>409</lpage> (<year>2005</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Chen Q."><surname>Chen</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhou L."><surname>Zhou</surname>, <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Shine H. D."><surname>Shine</surname>, <given-names>H. D.</given-names></string-name> <article-title hwp:id="article-title-5">Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord</article-title>. <source hwp:id="source-4">J Neurotrauma</source> <volume>23</volume>, <fpage>1254</fpage>–<lpage>1260</lpage> (<year>2006</year>).</citation></ref><ref id="c5" hwp:id="ref-5"><label>5</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Chen Q."><surname>Chen</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smith G. M."><surname>Smith</surname>, <given-names>G. M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Shine H. D."><surname>Shine</surname>, <given-names>H. D.</given-names></string-name> <article-title hwp:id="article-title-6">Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury</article-title>. <source hwp:id="source-5">Exp Neurol</source> <volume>209</volume>, <fpage>497</fpage>–<lpage>509</lpage> (<year>2008</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Zhou L."><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Baumgartner B. J."><surname>Baumgartner</surname>, <given-names>B. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hill-Felberg S. J."><surname>Hill-Felberg</surname>, <given-names>S. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="McGowen L. R."><surname>McGowen</surname>, <given-names>L. R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Shine H. D."><surname>Shine</surname>, <given-names>H. D.</given-names></string-name> <article-title hwp:id="article-title-7">Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord</article-title>. <source hwp:id="source-6">J Neurosci</source> <volume>23</volume>, <fpage>1424</fpage>–<lpage>1431</lpage>, (<year>2003</year>).</citation></ref><ref id="c7" hwp:id="ref-7"><label>7</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Chen H. H."><surname>Chen</surname>, <given-names>H. H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tourtellotte W. G."><surname>Tourtellotte</surname>, <given-names>W. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Frank E."><surname>Frank</surname>, <given-names>E.</given-names></string-name> <article-title hwp:id="article-title-8">Muscle spindle-derived neurotrophin 3 regulates synaptic connectivity between muscle sensory and motor neurons</article-title>. <source hwp:id="source-7">J Neurosci</source> <volume>22</volume>, <fpage>3512</fpage>–<lpage>3519</lpage> (<year>2002</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2"><label>8</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Patel T. D."><surname>Patel</surname>, <given-names>T. D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-9">Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents</article-title>. <source hwp:id="source-8">Neuron</source> <volume>38</volume>, <fpage>403</fpage>–<lpage>416</lpage> (<year>2003</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Zhang J."><surname>Zhang</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats</article-title>. <source hwp:id="source-9">Neurosci</source> <volume>222</volume>, <fpage>1</fpage>–<lpage>9</lpage> (<year>2012</year>).</citation></ref><ref id="c10" hwp:id="ref-10"><label>10</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Zhang W. R."><surname>Zhang</surname>, <given-names>W. R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-11">Reduction of tyrosine kinase B and tyrosine kinase C inductions by treatment with neurotrophin-3 after transient middle cerebral artery occlusion in rat</article-title>. <source hwp:id="source-10">Neurosci Lett</source> <volume>276</volume>, <fpage>161</fpage>–<lpage>164</lpage> (<year>1999</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Zhang W. R."><surname>Zhang</surname>, <given-names>W. R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-12">Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats</article-title>. <source hwp:id="source-11">Brain Res</source> <volume>842</volume>, <fpage>211</fpage>–<lpage>214</lpage> (<year>1999</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Grill R."><surname>Grill</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Murai K."><surname>Murai</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Blesch A."><surname>Blesch</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gage F. H."><surname>Gage</surname>, <given-names>F. H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Tuszynski M. H."><surname>Tuszynski</surname>, <given-names>M. H.</given-names></string-name> <article-title hwp:id="article-title-13">Cellular delivery of neurotrophin-3 promotes corticospinal axon growth and partial functional recovery after spinal cord injury</article-title>. <source hwp:id="source-12">J Neurosci</source> <volume>17</volume>, <fpage>5560</fpage>–<lpage>5572</lpage> (<year>1997</year>).</citation></ref><ref id="c13" hwp:id="ref-13"><label>13</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Schnell L."><surname>Schnell</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schneider R."><surname>Schneider</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kolbeck R."><surname>Kolbeck</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barde Y. A."><surname>Barde</surname>, <given-names>Y. A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Schwab M. E."><surname>Schwab</surname>, <given-names>M. E.</given-names></string-name> <article-title hwp:id="article-title-14">Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesions</article-title>. <source hwp:id="source-13">Nature</source> <volume>367</volume>, <fpage>170</fpage>–<lpage>172</lpage> (<year>1994</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Fortun J."><surname>Fortun</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Puzis R."><surname>Puzis</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pearse D. D."><surname>Pearse</surname>, <given-names>D. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gage F. H."><surname>Gage</surname>, <given-names>F. H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bunge M. B."><surname>Bunge</surname>, <given-names>M. B.</given-names></string-name> <article-title hwp:id="article-title-15">Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI</article-title>. <source hwp:id="source-14">J Neurotrauma</source> <volume>26</volume>, <fpage>941</fpage>–<lpage>953</lpage> (<year>2009</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2"><label>15</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Brock J. H."><surname>Brock</surname>, <given-names>J. H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-16">Local and remote growth factor effects after primate spinal cord injury</article-title>. <source hwp:id="source-15">J Neurosci</source> <volume>30</volume>, <fpage>9728</fpage>–<lpage>9737</lpage> (<year>2010</year>).</citation></ref><ref id="c16" hwp:id="ref-16"><label>16</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Altar C. A."><surname>Altar</surname>, <given-names>C. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Criden M. R."><surname>Criden</surname>, <given-names>M. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lindsay R. M."><surname>Lindsay</surname>, <given-names>R. M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="DiStefano P. S."><surname>DiStefano</surname>, <given-names>P. S.</given-names></string-name> <article-title hwp:id="article-title-17">Characterization and topography of high-affinity 125I-neurotrophin-3 binding to mammalian brain</article-title>. <source hwp:id="source-16">J Neurosci</source> <volume>13</volume>, <fpage>733</fpage>–<lpage>743</lpage> (<year>1993</year>).
</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.17" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Barrette B."><surname>Barrette</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vallieres N."><surname>Vallieres</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dube M."><surname>Dube</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lacroix S."><surname>Lacroix</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-18">Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system</article-title>. <source hwp:id="source-17">Mol Cell Neurosci</source>, (<year>2007</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2"><label>18</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Sahenk Z."><surname>Sahenk</surname>, <given-names>Z.</given-names></string-name> <article-title hwp:id="article-title-19">Pilot clinical trial of NT-3 in CMT1A patients</article-title>. <source hwp:id="source-18">Prog Neurotherapeutics Neuropsychopharm</source> <volume>2</volume>, <fpage>97</fpage>–<lpage>108</lpage> (<year>2007</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Parkman H. P."><surname>Parkman</surname>, <given-names>H. P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-20">Neurotrophin-3 improves functional constipation</article-title>. <source hwp:id="source-19">Am J Gastroenterol</source> <volume>98</volume>, <fpage>1338</fpage>–<lpage>1347</lpage> (<year>2003</year>).</citation></ref><ref id="c20" hwp:id="ref-20"><label>20</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Chaudhry V."><surname>Chaudhry</surname>, <given-names>V.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-21">Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects</article-title>. <source hwp:id="source-20">Muscle Nerve</source> <volume>23</volume>, <fpage>189</fpage>–<lpage>192</lpage> (<year>2000</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2"><label>21</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Coulie B."><surname>Coulie</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans</article-title>. <source hwp:id="source-21">Gastroenterology</source> <volume>119</volume>, <fpage>41</fpage>–<lpage>50</lpage> (<year>2000</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2"><label>22</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Lee J."><surname>Lee</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Friese A."><surname>Friese</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mielich M."><surname>Mielich</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sigrist M."><surname>Sigrist</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Arber S."><surname>Arber</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-23">Scaling proprioceptor gene transcription by retrograde NT3 signaling</article-title>. <source hwp:id="source-22">PLoS One</source> <volume>7</volume>, <fpage>e45551</fpage>, (<year>2012</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Wang Z."><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li L."><surname>Li</surname>, <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Frank E."><surname>Frank</surname>, <given-names>E.</given-names></string-name> <article-title hwp:id="article-title-24">The role of muscle spindles in the development of the monosynaptic stretch reflex</article-title>. <source hwp:id="source-23">J Neurophysiol</source> <volume>108</volume>, <fpage>83</fpage>–<lpage>90</lpage> (<year>2012</year>).</citation></ref><ref id="c24" hwp:id="ref-24"><label>24</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Chen H.-H."><surname>Chen</surname>, <given-names>H.-H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tourtellotte W. G."><surname>Tourtellotte</surname>, <given-names>W. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Frank E."><surname>Frank</surname>, <given-names>E.</given-names></string-name> <article-title hwp:id="article-title-25">Muscle Spindle-Derived Neurotrophin 3 Regulates Synaptic Connectivity between Muscle Sensory and Motor Neurons</article-title>. <source hwp:id="source-24">The Journal of Neuroscience</source> <volume>22</volume>, <fpage>3512</fpage>–<lpage>3519</lpage> (<year>2002</year>).</citation></ref><ref id="c25" hwp:id="ref-25"><label>25</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Taylor M. D."><surname>Taylor</surname>, <given-names>M. D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-26">Overexpression of neurotrophin-3 in skeletal muscle alters normal and injury-induced limb control</article-title>. <source hwp:id="source-25">Somatosens Mot Res</source> <volume>18</volume>, <fpage>286</fpage>–<lpage>294</lpage> (<year>2001</year>).</citation></ref><ref id="c26" hwp:id="ref-26"><label>26</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Yan Q."><surname>Yan</surname>, <given-names>Q.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-27">Influences of neurotrophins on mammalian motoneurons in vivo</article-title>. <source hwp:id="source-26">J Neurobiol</source> <volume>24</volume>, <fpage>1555</fpage>–<lpage>1577</lpage> (<year>1993</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2"><label>27</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="DiStefano P. S."><surname>DiStefano</surname>, <given-names>P. S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons</article-title>. <source hwp:id="source-27">Neuron</source> <volume>8</volume>, <fpage>983</fpage>–<lpage>993</lpage> (<year>1992</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2 xref-ref-28-3"><label>28</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Truelsen T."><surname>Truelsen</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-29">Stroke incidence and prevalence in Europe: a review of available data</article-title>. <source hwp:id="source-28">Eur J Neurol</source> <volume>13</volume>, <fpage>581</fpage>–<lpage>598</lpage> (<year>2006</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2 xref-ref-29-3 xref-ref-29-4 xref-ref-29-5"><label>29</label><citation publication-type="other" citation-type="journal" ref:id="427864v2.29" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Wayman C."><surname>Wayman</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-30">Performing permanent distal middle cerebral artery with common carotid occlusion in aged rats to study cortical ischemia with sustained disability</article-title>. <source hwp:id="source-29">Journal of Online Visualized Experiments</source>, (In Press).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Harraf F."><surname>Harraf</surname>, <given-names>F.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-31">A multicentre observational study of presentation and early assessment of acute stroke</article-title>. <source hwp:id="source-30">Bmj</source> <volume>325</volume>, <fpage>17</fpage>, (<year>2002</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2 xref-ref-31-3"><label>31</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Takeoka A."><surname>Takeoka</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vollenweider I."><surname>Vollenweider</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Courtine G."><surname>Courtine</surname>, <given-names>G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Arber S."><surname>Arber</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-32">Muscle spindle feedback directs locomotor recovery and circuit reorganization after spinal cord injury</article-title>. <source hwp:id="source-31">Cell</source> <volume>159</volume>, <fpage>1626</fpage>–<lpage>1639</lpage> (<year>2014</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="McKenna J. E."><surname>McKenna</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Prusky G. T."><surname>Prusky</surname>, <given-names>G. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Whishaw I. Q."><surname>Whishaw</surname>, <given-names>I. Q.</given-names></string-name> <article-title hwp:id="article-title-33">Cervical motoneuron topography reflects the proximodistal organization of muscles and movements of the rat forelimb: a retrograde carbocyanine dye analysis</article-title>. <source hwp:id="source-32">J Comp Neurol</source> <volume>419</volume>, <fpage>286</fpage>–<lpage>296</lpage> (<year>2000</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1 xref-ref-33-2"><label>33</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Tosolini A. P."><surname>Tosolini</surname>, <given-names>A. P.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Morris R."><surname>Morris</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-34">Spatial characterization of the motor neuron columns supplying the rat forelimb</article-title>. <source hwp:id="source-33">Neuroscience</source> <volume>200</volume>, <fpage>19</fpage>–<lpage>30</lpage> (<year>2012</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Poduslo J. F."><surname>Poduslo</surname>, <given-names>J. F.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Curran G. L."><surname>Curran</surname>, <given-names>G. L.</given-names></string-name> <article-title hwp:id="article-title-35">Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF</article-title>. <source hwp:id="source-34">Brain Res Mol Brain Res</source> <volume>36</volume>, <fpage>280</fpage>–<lpage>286</lpage> (<year>1996</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Chaudhry V."><surname>Chaudhry</surname>, <given-names>V.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-36">Tolerability of recombinant-methionyl human neurotrophin-3 (r-metHuNT3) in healthy subjects</article-title>. <source hwp:id="source-35">Muscle &amp; nerve</source> <volume>23</volume>, <fpage>189</fpage>–<lpage>192</lpage> (<year>2000</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Sahenk Z."><surname>Sahenk</surname>, <given-names>Z.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-37">NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients</article-title>. <source hwp:id="source-36">Neurol</source> <volume>65</volume>, <fpage>681</fpage>–<lpage>689</lpage> (<year>2005</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Wahl A. S."><surname>Wahl</surname>, <given-names>A. S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-38">Neuronal repair. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke</article-title>. <source hwp:id="source-37">Science</source> <volume>344</volume>, <fpage>1250</fpage>–<lpage>1255</lpage> (<year>2014</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Yamamoto M."><surname>Yamamoto</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sobue G."><surname>Sobue</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yamamoto K."><surname>Yamamoto</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Terao S."><surname>Terao</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mitsuma T."><surname>Mitsuma</surname>, <given-names>T.</given-names></string-name> <article-title hwp:id="article-title-39">Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues</article-title>. <source hwp:id="source-38">Neurochem Res</source> <volume>21</volume>, <fpage>929</fpage>–<lpage>938</lpage> (<year>1996</year>).</citation></ref><ref id="c39" hwp:id="ref-39"><label>39</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Terenghi G."><surname>Terenghi</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mann D."><surname>Mann</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kopelman P. G."><surname>Kopelman</surname>, <given-names>P. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Anand P."><surname>Anand</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-40">trkA and trkC expression is increased in human diabetic skin</article-title>. <source hwp:id="source-39">Neurosci Lett</source> <volume>228</volume>, <fpage>33</fpage>–<lpage>36</lpage> (<year>1997</year>).</citation></ref><ref id="c40" hwp:id="ref-40"><label>40</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Duberley R. M."><surname>Duberley</surname>, <given-names>R. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Johnson I. P."><surname>Johnson</surname>, <given-names>I. P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Anand P."><surname>Anand</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leigh P. N."><surname>Leigh</surname>, <given-names>P. N.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cairns N. J."><surname>Cairns</surname>, <given-names>N. J.</given-names></string-name> <article-title hwp:id="article-title-41">Neurotrophin-3-like immunoreactivity and Trk C expression in human spinal motoneurones in amyotrophic lateral sclerosis</article-title>. <source hwp:id="source-40">J Neurol Sci</source> <volume>148</volume>, <fpage>33</fpage>–<lpage>40</lpage> (<year>1997</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Arvidsson U."><surname>Arvidsson</surname>, <given-names>U.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-42">trkC-like immunoreactivity in the primate descending serotonergic system</article-title>. <source hwp:id="source-41">European journal of neuroscience</source> <volume>6</volume>, <fpage>230</fpage>–<lpage>236</lpage> (<year>1994</year>).</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Harkema S."><surname>Harkema</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-43">Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study</article-title>. <source hwp:id="source-42">Lancet</source> <volume>377</volume>, <fpage>1938</fpage>–<lpage>1947</lpage> (<year>2011</year>).</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>43</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Hiltunen J. O."><surname>Hiltunen</surname>, <given-names>J. O.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Laurikainen A."><surname>Laurikainen</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Klinge E."><surname>Klinge</surname>, <given-names>E.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Saarma M."><surname>Saarma</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-44">Neurotrophin-3 is a target-derived neurotrophic factor for penile erection-inducing neurons</article-title>. <source hwp:id="source-43">Neuroscience</source> <volume>133</volume>, <fpage>51</fpage>–<lpage>58</lpage> (<year>2005</year>).</citation></ref><ref id="c44" hwp:id="ref-44"><label>44</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Curtis R."><surname>Curtis</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms</article-title>. <source hwp:id="source-44">Mol Cell Neurosci</source> <volume>12</volume>, <fpage>105</fpage>–<lpage>118</lpage> (<year>1998</year>).</citation></ref><ref id="c45" hwp:id="ref-45"><label>45</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Tria M. A."><surname>Tria</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fusco M."><surname>Fusco</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vantini G."><surname>Vantini</surname>, <given-names>G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mariot R."><surname>Mariot</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-46">Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats</article-title>. <source hwp:id="source-45">Exp Neurol</source> <volume>127</volume>, <fpage>178</fpage>–<lpage>183</lpage> (<year>1994</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46</label><citation publication-type="journal" citation-type="journal" ref:id="427864v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Helgren M. E."><surname>Helgren</surname>, <given-names>M. E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-47">Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy</article-title>. <source hwp:id="source-46">J Neurosci</source> <volume>17</volume>, <fpage>372</fpage>–<lpage>382</lpage> (<year>1997</year>).</citation></ref></ref-list><ack hwp:id="ack-1"><title hwp:id="title-21">Acknowledgments</title><p hwp:id="p-35">The research leading to these results has received funding from the European Research Council under the European Union’s Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 309731 and by a “Serendipity Grant” from The Dunhill Medical Trust (grant number: SA21/0512). The NT3 ELISA was funded by Brain Research UK (201617-04) and the Medical Research Council (S026053/1 to LDFM). AV received funding from the University of Greifswald (Käthe-Kluth-Research Group). The funders had no role in the study design, data collection and the analysis, decision to publish, or preparation of the article. The funders had no role in the study design, data collection and the analysis, decision to publish, or preparation of the paper.</p></ack></back></article>
